Professional Documents
Culture Documents
fructose diet stimulates lipogenesis when energy balance is neutral and both weight and body fat
are maintained.
A key metabolic pathway that is important in this study is the conversion of sugar to fat
in the liver, otherwise known as lipogenesis. After fructose is absorbed in the intestine, it is
rapidly taken up by the liver. The enzyme fructokinase is present in the liver, which
phosphorylates fructose to fructose-1-phosphate. Fructose-1-phosphate can then be converted to
dihydroxyacetone phosphate and glyceraldehyde and enter the glycolytic pathway. The
glycolytic pathway yields pyruvate, which is converted to acetyl-CoA via the pyruvate
dehydrogenase complex. In the fed state, acetyl-CoA is converted into fatty acids during fatty
acid synthesis. During this process, malonyl-CoA is added to acetyl-CoA via a complex of
enzymes known as the fatty acid synthase complex. The series of reactions involved in fatty acid
synthesis include condensation, reduction with NADPH, dehydration, and reduction with
NADPH. The result of this is synthesis of a 16-carbon fatty acid known as palmitic acid. The
fatty acids that are synthesized are then added to glycerol to form triglycerides. Triglycerides are
exported from the liver on very low-density lipoproteins (VLDLs) to peripheral tissues and
stored in adipose tissue. As the rate of lipogenesis increases in the liver, as it does during periods
of excessive simple carbohydrate intake, not all of the triglycerides are exported to peripheral
tissues. The triglycerides that are not exported are retained in the liver, which can result in fatty
liver.
In order to understand the effects of lipogenesis in the liver on substrate utilization, the
effects of lipogenesis on the regulation of fatty acid oxidation (beta-oxidation) must be
examined. During lipogenesis, acetyl-CoA must be converted to malonyl-CoA. When rates of
lipogenesis increase, the concentration of malonyl-CoA also increases in the cell. Malonyl-CoA
is a substance that inhibits the enzyme carnitine acyltransferase I, which has the effect of
inhibiting the beta-oxidation pathway. Carnitine acyltransferase I is involved in the transport of
fatty acyl-CoA into the mitochondria for beta-oxidation. When this enzyme is inhibited, the
transport does not occur and thus newly formed fatty acids are not transported into the
mitochondria for oxidation. The inhibition of beta-oxidation changes the ratio of substrate
utilization, as demonstrated in the results of the study showing decreased lipid utilization.
Understanding the metabolic pathway of lipogenesis was integral for understanding the
results of this study. In addition, understanding the regulatory mechanisms of the beta-oxidation
pathway and how intermediaries in lipogenesis inhibit beta-oxidation is also essential.
Reference
Schwarz, J.-M., Noworolski, S. M., Wen, M. J., Dyachenko, A., Prior, J. L., Weinberg, M. E.,
Mulligan, K. (2015). Effect of a High-Fructose Weight-Maintaining Diet on Lipogenesis
and Liver Fat. The Journal of Clinical Endocrinology and Metabolism, 100(6), 2434
2442. http://doi.org/10.1210/jc.2014-3678